"My zaopiekujemy się Twoim zdrowiem serdecznie"

During the past decade, Unicardia Specjalistyczne Centrum Leczenia Ch.Serca i Naczyn conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Unicardia Specjalistyczne Centrum Leczenia Ch.Serca i Naczyn" are "Atrial Fibrillation" (1 trials), "Crohn Disease" (1 trials), "Crohn's Disease" (1 trials), "Heart Failure" (1 trials) and "Prevention of Stroke or Systemic Embolism" (1 trials). Many other conditions were trialed in "Unicardia Specjalistyczne Centrum Leczenia Ch.Serca i Naczyn" in a lesser frequency.

Most popular intervention types in "Unicardia Specjalistyczne Centrum Leczenia Ch.Serca i Naczyn" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials), "Asundexian (BAY2433334)" (1 trials) and "Asundexian matching placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Unicardia Specjalistyczne Centrum Leczenia Ch.Serca i Naczyn" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Unicardia Specjalistyczne Centrum Leczenia Ch.Serca i Naczyn". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Unicardia Specjalistyczne Centrum Leczenia Ch.Serca i Naczyn, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Unicardia Specjalistyczne Centrum Leczenia Ch.Serca i Naczyn, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".